Skip to main content

Resmed Value Stock - Dividend - Research Selection

Resmed

ISIN: US7611521078 , WKN: 895878

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield%
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



DescriptionData
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications that diagnose, treat, and manage respiratory disorders comprising sleep apnea, chronic obstructive pulmonary disease, neuromuscular disease, and other chronic diseases. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, portable oxygen concentrators, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides U-Sleep, which enables automated patient coaching through a text, email, or interactive voice phone call; AirView that enables remote monitoring, over-the-air trouble shooting, and changing of device settings; and myAir, a patient engagement application that offers sleep data and a daily score based on their previous night's data, as well as connectivity module and propeller solutions. In addition, it provides business management software and services to out-of-hospital providers, home medical equipment, pharmacy, home infusion, orthotics, and prosthetics; and HEALTHCAREfirst and MatrixCare solutions. The company markets its products to sleep clinics, home healthcare dealers, patients, hospitals, physicians, and third-party payers through a network of distributors and direct sales force in approximately 140 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Should You Hold STERIS (STE) Stock Now? Here's What to Consider

2024-07-08
STERIS' (STE) Healthcare business and strong rebound prospects of the AST segment appear encouraging. However, macroeconomic concerns remain a challenge.

ResMed to Report Fourth Quarter Fiscal 2024 Earnings on August 1, 2024

2024-07-03
SAN DIEGO, July 03, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the fourth quarter of fiscal year 2024 on Thursday, August 1, 2024, after the New York Stock Exchange closes. Following the release, ResMed management will host a webcast to discuss the results. Other forward-looking and material information may also be discussed during the webcast. Earnings webcast details: Location: http://investor.resmed.com Date:

ResMed: Potentially Undervalued Amid Increasing Sleep Apnea Awareness

2024-07-03
ResMed's USP is in its integrated approach to sleep and respiratory care, combining innovative hardware with advanced software. Find out more on RMD stock here.

Omnicell (OMCL) Banks on Product Launches, Global Growth

2024-07-03
Omnicell (OMCL) remains a key player in automating and modernizing global medication management infrastructure.

Zacks.com featured highlights include ResMed, Badger Meter, Leidos and Ingersoll Rand

2024-07-03
ResMed, Badger Meter, Leidos and Ingersoll Rand are part of the Zacks Screen of the Week article.

Thermo Fisher (TMO) Brings Biobased, Sustainable Films for BPCs

2024-07-03
Thermo Fisher (TMO) has launched biobased solutions to help reduce the climate impact on the manufacturing of therapies.

ResMed: Asymmetrical Value Opportunity With High Prospect Of Re-Rating

2024-07-03
ResMed’s competitive advantages in the sleep domain are durable, and its underlying business remains strong. Read why I'm bullish on RMD stock here.

4 Top Earnings Growth Stocks to Buy: RMD, BMI, LDOS, IR

2024-07-02
Stocks such as ResMed (RMD), Badger Meter (BMI), Leidos (LDOS) and Ingersoll Rand (IR) are currently exhibiting superb earnings growth.

How Great Is It to Have Customers That Absolutely Love You and Plan to Never Leave You?

2024-07-02
We also talk about weight loss drugs and sleep apnea, and other stock market news.

Sound Investments: 3 Stocks to Buy for a Good Night’s Rest

2024-06-29
When one thinks about safe stocks to buy, investors generally think of blue-chip large-cap companies such as Berkshire Hathaway (NYSE:BRK-A, NYSE:BRK-B) or Microsoft (NASDAQ:MSFT). However, manufacturers of beds, sleep apnea machines and proper lighting are participating in a $585 billion global sleep economy. A November 2023 article from Harvard Health Publishing, the media division of Harvard Medical School, published 8 secrets to a good night’s sleep. InvestorPlace - Stock Market News, Stock